The role of CYP 3A4 and 1A1 in amiodarone-induced hepatocellular toxicity.

作者: Qiangen Wu , Baitang Ning , Jiekun Xuan , Zhen Ren , Lei Guo

DOI: 10.1016/J.TOXLET.2016.04.016

关键词:

摘要: Amiodarone is a widely used potent antiarrhythmic for the treatment of cardiac disease; however, its use often discontinued due to numerous adverse effects, including hepatotoxicity. To investigate role drug metabolism in this liver toxicity, amiodarone and major metabolite desethylamiodarone were incubated with HepG2 cells overexpressing series cytochrome P450 (CYP) isoforms. Significantly higher cytotoxicity was observed CYP3A4 or CYP1A1, compared that empty vector transduced control cells. Further, levels more hepatotoxic detected CYP1A1 expressed The inhibitor ketoconazole α-naphthoflavone drastically inhibited desethylamiodarone. Along inhibition CYP3A4, significantly reduced. These data indicate by plays an important hepatocellular toxicity amiodarone.

参考文章(35)
Michael Weiss, The Anomalous Pharmacokinetics of Amiodarone Explained by Nonexponential Tissue Trapping Journal of Pharmacokinetics and Biopharmaceutics. ,vol. 27, pp. 383- 396 ,(1999) , 10.1023/A:1020965005254
Marwa E. Elsherbiny, Ayman O.S. El-Kadi, Dion R. Brocks, The metabolism of amiodarone by various CYP isoenzymes of human and rat, and the inhibitory influence of ketoconazole Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences. ,vol. 11, pp. 147- 159 ,(2008) , 10.18433/J3SG66
K. Ohyama, M. Nakajima, M. Suzuki, N. Shimada, H. Yamazaki, T. Yokoi, Inhibitory effects of amiodarone and its N‐deethylated metabolite on human cytochrome P450 activities: Prediction of in vivo drug interactions British Journal of Clinical Pharmacology. ,vol. 49, pp. 244- 253 ,(2000) , 10.1046/J.1365-2125.2000.00134.X
Jiekun Xuan, Si Chen, Baitang Ning, William H. Tolleson, Lei Guo, Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity. Chemico-Biological Interactions. ,vol. 255, pp. 63- 73 ,(2016) , 10.1016/J.CBI.2015.10.009
Jean-Marc Pascussi, Lionel Drocourt, Jean-Michel Fabre, Patrick Maurel, Marie-José Vilarem, Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Molecular Pharmacology. ,vol. 58, pp. 361- 372 ,(2000) , 10.1124/MOL.58.2.361
Tsuyoshi Yokoi, Sumika Nakamura, Katsuhiro Ohyama, Miki Nakajima, Hiroshi Yamazaki, Noriaki Shimada, A significant role of human cytochrome P450 2C8 in amiodarone N-deethylation : an approach to predict the contribution with relative activity factor Drug Metabolism and Disposition. ,vol. 28, pp. 1303- 1310 ,(2000)
James H. Lewis, Richard C. Ranard, Anthony Caruso, Lawrence K. Jackson, Florabel Mullick, Kamal G. Ishak, Leonard B. Seeff, Hyman J. Zimmerman, Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients. Hepatology. ,vol. 9, pp. 679- 685 ,(1989) , 10.1002/HEP.1840090504
Anja Zahno, Karin Brecht, Réjane Morand, Swarna Maseneni, Michael Török, Peter W. Lindinger, Stephan Krähenbühl, The role of CYP3A4 in amiodarone-associated toxicity on HepG2 cells Biochemical Pharmacology. ,vol. 81, pp. 432- 441 ,(2011) , 10.1016/J.BCP.2010.11.002
Marwa E. Elsherbiny, Ayman O.S. El-Kadi, Dion R. Brocks, The effect of β-naphthoflavone on the metabolism of amiodarone by hepatic and extra-hepatic microsomes Toxicology Letters. ,vol. 195, pp. 147- 154 ,(2010) , 10.1016/J.TOXLET.2010.03.019